1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News AUGUST 2016

Anti-Infective Drug News AUGUST 2016

  • August 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Local Zika Transmission Heightens Diagnostic Development
Industry Brief - FDA Grants QIDP/Fast Track Designations To Morphochem's MCB3837 To Treat CDI
Industry Brief - Valneva Completes Phase II Trial Clostridium Difficile Vaccine Candidate
Industry Brief - Taiho Seeks Japanese Approval For Zosyn In Complicated Skin/Soft Tissue Infections
Industry Brief - EMA Approves Xydalba Single-Dose Infusion
Industry Brief - FDA Approves Aurobindo's Linezolid
Industry Brief - Valeant Relaunches Ofloxacin Otic Solution
Industry Brief - First Patient Dosed In Omadacycline Phase III ABSSSIs Study
Industry Brief - Novan Announces First Patient Dosed In Phase II Anti-Fungal Program
Industry Brief - NovaDigm Reports Positive Results From NDV-3A Phase IIa RVVC Study
Industry Brief - Pulmatrix' PUR1900 Granted FDA Orphan Drug Designation In CF
Industry Brief - Prokarium Secures Grant To Develop Vaccines Against Emerging Diseases/ Bioterrorist Threats
Industry Brief - GSK Ships 2016-17 Quadrivalent Influenza Vaccines For US market
Industry Brief - Sanofi's Quadrivalent Influenza Vaccine Approved In UK
Industry Brief - FDA Releases First Doses Of 2016/17 Fluzone Vaccine For Shipment
Industry Brief - Merck's Ebola Zaire Vaccine Granted FDA Breakthrough Therapy Designation And EMA PRIME Status
Industry Brief - TREK Gains Worldwide Rights To Lomibuvir/Merimepodib From Vertex
Industry Brief - FDA Approves Viekira XR To Treat GT1 HCV
Industry Brief - EC Approves Zepatier To Treat Chronic HCV GT1/4
Industry Trend Analysis - Pre-Olympics Update: Zika Challenges To Remain
Industry Brief - SIGA To Complete Enrollment In Final Phase III Study Of Tpoxx
Industry Brief - FDA Approves And Releases First Doses Of Flublok For 2016/17
Industry Brief - Natco Gains Oseltamivir FDA Approval
Industry Brief - Shipment Of Fluad Commences To US For 2016-2017 Flu Season
Industry Brief - EMA's CHMP Adopts Positive Opinion On Gilead's Truvada For HIV
Industry Trend Analysis - MSF Report Highlights At-Threat Generic Production
Industry Brief - Odefsey Meets Primary Objective In Two Phase IIIb HIV-1 Studies
Industry Brief - First Patient Enrolled Under Newly Modified Protocol In PRO 140 Phase III HIV Study
Industry Trend Analysis - EMA Action Will Have Greatest Impact On Indian Industry
Industry Brief - Lupin Gains Fosamprenavir Tentative Approval
Industry Brief - GeoVax Secures NIAID Contract To Develop GOVX-B11 HIV Vaccine For Advanced Clinical Trials
Industry Brief - IAVI Awarded NIH Contract To Expedite AIDS Vaccine Development
Industry Trend Analysis - Simplifying Therapies Holds Promise In HIV
Industry Brief - Aldevron Completes Production Of Malaria DNA Vaccine Under NMRC Contract
Industry Brief - Ligand Enters Multi-Programme LTP Technology Deal With Nucorion
Industry Brief - Kyowa To Acquire 21 Long-Listed Products From Shionogi
Industry Brief - Dyadic Reports Termination Of Agreement With Sanofi
Industry Brief - Takeda To Terminate Prevenar13/Benefix Japanese Distribution Deal With Pfizer
Industry Brief - Basilea Expands MENA Distribution Deal With Hikma For Cresemba
Industry Brief - Xycrobe Enters Research Collaboration With J&J Innovation
Industry Brief - CHMP Issues Positive Opinion For Shorter Treatment Duration With Viekirax In HCV GT4
Industry Brief - Inovio To Independently Develop Hepatitis B DNA Immunotherapy
Industry Brief - ARTES And Burnet Join To Develop Novel Hepatitis C Vaccine
Industry Brief - Medivir Out-Licenses MIV-802 Rights To Trek

Table Of Contents

Anti-Infective Drug News AUGUST 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Anti-Infective Market in Tanzania

  • December 2016
    9 pages
  • Anti-Infective  

  • Tanzania  

    Africa  

View report >

Opioid Market in Iran

  • December 2016
    8 pages
  • Opioid  

  • Iran  

View report >

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.